100 KING STREET WEST, TORONTO, A6
Medicus Pharma Ltd. Completes Unregistered Sales of Common Shares
Equity Distribution Agreement with Maxim Group and Yorkville Securities
Enters Into $5.1 Million Warrant Inducement
Appoints Carolyn Bonner as Chief Financial Officer in Addition to Her Role as President
Provides Corporate Updates and Reports Third Quarter 2025 Financial Highlights
Medicus Pharma Ltd Completes $2.53M in Unregistered Share Sales
$8.0 MILLION NON-DILUTIVE DEBENTURE FINANCING
Changes in Board, Management or Compensation
FY 2025
Q3
Q2
Q1
Amended Annual Report
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
Definitive Proxy Statement
PRER14A
PRE 14A
Statement of Changes in Beneficial Ownership
Post-Effective Amendment to Registration Statement
Regulation A Offering Circular Supplement (Annual Report)